Delivering extraordinary. Empowering ordinary.

We’re developing novel oral medicines for rare diseases to help patients take part in the everyday activities they enjoy.

Learn More

Structure-guided Drug Design

We combine traditional cell biology with medicinal chemistry to build synthetic compounds that bind to specific protein targets to fight disease.

See Our Science

Building a Rare Disease Drug Portfolio

We are developing a pipeline of oral drugs for rare diseases, including our next generation kallikrein inhibitor for hereditary angioedema (HAE).

View Our Pipeline

Join Our Team

We are a collection of passionate individuals united by a commitment to scientific excellence and an unwavering focus on the needs of patients.